Speakers: Ed Ha (Angiex), Dian Su (Genentech), Chunze Li (Genentech), Tao Li (Seattle Genetics), Melissa Schutten (Genentech)
Organizers: Thomas Pillow (Genentech)
Date: 2021-05-26
Time: 8:30-13:30 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor: (1)Catalent
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-05-25  (it will close sooner if the seating cap is reached)

About the Topic

Antibody-drug conjugates harness both the potent activity of a small molecule and the selectivity of a monoclonal antibody. This class of molecules has exploded in interest and success in recent years with >80 molecules undergoing clinical evaluation and 5 new ADCs approved since mid-2019. The workshop will provide the most recent learnings and critical aspects of the discovery and development for this class of bioconjugates.

Agenda:

8:30 am – 8:40 am      Welcome Remarks -Thomas Pillow (Genentech; PBSS)

8:40 am – 9:25 am       Chemistry and Conjugation of ADCs – Ed Ha (Angiex)

9:25 am – 10:10 am     Small Molecule DMPK for ADCs – Dian Su (Genentech)

10:10 am – 10:55 am   Dose Optimization for ADCs – Chunze Li (Genentech)

10:55 am – 11:05 am   Major Sponsor Presentation – Catalent

11:05 am – 11:15 am   Break

11:15 am – 12:00 pm  CMC Challenges and Opportunities in ADC Drug Development – Tao Li (Seattle Genetics)

12:00 pm – 12:45 pm  ADC Safety – Melissa Schutten(Genentech)

12:45 pm – 1:30 pm    Panel Discussion – All speakers (Moderator: Thomas Pillow)

Event Information

Event Topic:
Antibody-Drug Conjugates: Discovery to Development

Event Description:

Date/Time:
Date(s) - 05/26/21
8:30 am - 1:30 pm

Event Location:
Other:

Event Details

Event Type